Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Bernhard Hemmer, Marco Capobianco et al.|The Lancet Neurology|2021Cited by 518
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel Whittam, Brigitte Wildemann, Álvaro Cobo‐Calvo et al.|Multiple Sclerosis and Related Disorders|2020Cited by 179
Treatment of MOG antibody associated disorders: results of an international survey.Daniel Whittam, Eric C. Klawiter, A. Jacob et al.|Research Padua Archive (University of Padua)|2020Cited by 139
Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient InterviewsJu‐Hong Min, Marius Ringelstein, Marco Capobianco et al.|Neurology and Therapy|2023Cited by 10
Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient InterviewsMarco Capobianco, Dean M. Wingerchuk, Marius Ringelstein et al.|Neurology and Therapy|2023Cited by 7